This content is machine translated Small cell lung carcinoma Durvalumab approved as first immunotherapy for patients with LS-SCLC Durvalumab has been approved as a monotherapy in Switzerland for the treatment of adult patients with unresectable small cell lung cancer (LS-SCLC, limited-stage small cell lung cancer) whose disease has...…
View Post 4 min This content is machine translated Immuno-oncological therapies CAR-T cell therapy for hematologic cancers Immunotherapies are now established pillars in the treatment of cancer. The principle of CAR-T cell therapy is that the body’s own T cells are programmed to destroy cancer cells through…
View Post 7 min This content is machine translated Medical oncology A multidisciplinary approach to an innovative future The ESMO Congress is a globally influential oncology platform for clinicians, researchers, patient advocates and healthcare professionals from around the world. Once again this year, the latest ground-breaking data was…
View Post 4 min This content is machine translated Cutaneous squamous cell carcinoma A dermato-oncological challenge in advanced stages The treatment options for locally advanced and metastatic forms of cutaneous squamous cell carcinoma (cSCC) have improved considerably thanks to immunotherapy with PD-1 inhibitors, as several clinical studies have impressively…
View Post 3 min This content is machine translated Bone tumors New treatment impulses for osteosarcoma fuel hope Osteosarcoma is one of the most common primary malignant bone tumors in children and young adults with a high risk of bone and lung metastases. Despite recent advances in neoadjuvant…
View Post 4 min This content is machine translated Allergic rhinitis International consensus paper summarizes important facts The “International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis” (ICAR: AR 2023) is a valuable tool to overcome therapeutic inertia and achieve the best possible outcomes in the treatment…
View Post 20 min This content is machine translated Head and Neck Tumors Current treatment options – an update Tumors of the head and neck were the seventh most common cancer worldwide in 2018. The most important risk factors include nicotine and alcohol consumption. The prognosis and multimodality treatment… CME-Test
View Post 7 min This content is machine translated Hematology and medical oncology The world of hematology and oncology research The rapid technological developments in diagnostics and innovations in multimodal therapy in the field of hematology and medical oncology were the focus of the annual conference. While immunotherapies with monoclonal…
View Post 6 min This content is machine translated Melanoma in advanced stages Treatment strategies in the adjuvant and neoadjuvant setting The introduction of checkpoint inhibitors and targeted therapy with kinase inhibitors revolutionized the treatment options for patients with advanced-stage melanoma. While there is already a lot of evidence for immunotherapy…
View Post 7 min This content is machine translated Lung cancer Current research results for optimized management The European Lung Cancer Congress brings together key multidisciplinary societies to advance science, disseminate education and improve the practice of lung cancer specialists worldwide. At this year’s event, attendees were…
View Post 6 min This content is machine translated Merkel cell carcinoma – a highly malignant skin tumor Overview of current guideline recommendations on diagnosis and treatment Merkel cell carcinoma is a rare but aggressive form of skin cancer. It mainly affects older people, with the median age at diagnosis being 75 years. Adjuvant radiotherapy is recommended…
